Literature DB >> 18362651

Effects of suppression of blinking on quality of vision in borderline cases of evaporative dry eye.

Shizuka Koh1, Naoyuki Maeda, Yuichi Hori, Tomoyuki Inoue, Hitoshi Watanabe, Yoko Hirohara, Toshifumi Mihashi, Takashi Fujikado, Yasuo Tano.   

Abstract

PURPOSE: To study the effects of suppression of blinking on quality of vision in borderline cases of evaporative dry eye.
METHODS: Ocular higher-order aberrations (HOAs) were measured sequentially for 30 seconds in 10 eyes with a short tear film breakup time (TBUT; 3.0 +/- 0.6 seconds) without ocular surface staining or tear deficiency. During measurements, the subjects suppressed blinking to every 10 seconds, which is more than double the TBUT. The aberration data were analyzed for comalike and spherical-like aberrations and total HOAs to the sixth-order Zernike polynomials.
RESULTS: Sequential changes in total HOAs in subjects with a short TBUT showed a sawtooth pattern with a marked upward curve that increased after blinking. From 5 to 9 seconds after blinking, the total HOAs were significantly higher than immediately after blinking (P < 0.001).
CONCLUSIONS: Serial HOA measurements showed that optical quality might deteriorate in subjects with a short TBUT by suppressed blinking, such as when gazing at a video display terminal, even with sufficient tear volume.

Entities:  

Mesh:

Year:  2008        PMID: 18362651     DOI: 10.1097/ICO.0b013e31815be9c8

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  17 in total

1.  Measurement of the time course of optical quality and visual deterioration during tear break-up.

Authors:  Haixia Liu; Larry Thibos; Carolyn G Begley; Arthur Bradley
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

2.  Higher order aberrations of the corneal surface after laser subepithelial keratomileusis.

Authors:  Hyun Ho Jung; Yong Sok Ji; Han Jin Oh; Kyung Chul Yoon
Journal:  Korean J Ophthalmol       Date:  2014-07-22

3.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

4.  Effect of airflow exposure on the tear meniscus.

Authors:  Shizuka Koh; Cynthia Tung; Ranjini Kottaiyan; James Zavislan; Geunyoung Yoon; James Aquavella
Journal:  J Ophthalmol       Date:  2012-04-10       Impact factor: 1.909

5.  Forward light scatter analysis of the eye in a spatially-resolved double-pass optical system.

Authors:  Jayoung Nam; Larry N Thibos; Arthur Bradley; Nikole Himebaugh; Haixia Liu
Journal:  Opt Express       Date:  2011-04-11       Impact factor: 3.894

Review 6.  Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes.

Authors:  Shizuka Koh
Journal:  Clin Ophthalmol       Date:  2015-05-15

7.  Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery.

Authors:  Yasushi Inoue; Shintarou Ochi
Journal:  Clin Ophthalmol       Date:  2016-12-23

8.  Changes in meibomian gland morphology and ocular higher-order aberrations in eyes with chalazion.

Authors:  Shima Fukuoka; Reiko Arita; Rika Shirakawa; Naoyuki Morishige
Journal:  Clin Ophthalmol       Date:  2017-05-30

9.  Longitudinal assessment of optical quality and intraocular scattering using the double-pass instrument in normal eyes and eyes with short tear breakup time.

Authors:  Hidenaga Kobashi; Kazutaka Kamiya; Kyohei Yanome; Akihito Igarashi; Kimiya Shimizu
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

10.  Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society.

Authors:  Takenori Inomata; Tina Shiang; Masao Iwagami; Fumika Sakemi; Keiichi Fujimoto; Yuichi Okumura; Mizu Ohno; Akira Murakami
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.